FDA Inspection 1086418 - Boehringer Ingelheim Pharma Gmbh & Co Kg - April 05, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Boehringer Ingelheim Pharma Gmbh & Co Kg

Record Details

This FDA Inspection record concerns Boehringer Ingelheim Pharma Gmbh & Co Kg, with an inspection on April 5, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Boehringer Ingelheim Pharma Gmbh & Co Kg
Inspection Date: April 5, 2019
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · dbf348fc-bd1b-46d8-8ac0-0e7e2889aa61

Violation Codes2

21 CFR 211.160(a)21 CFR 211.192

Full citation text and observation details available on the Dashboard.